Xenon Pharmaceuticals Inc. (XENE): Weighted Average Diluted Shares
79.25M
Year ended 2025-12-31
+9.4%
3-year compound annual growth
+18.1%
5-year compound annual growth
+18.7%
10-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 79.25M | +1.7% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | 77.89M | +16.5% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | 66.89M | +10.5% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | 60.54M | +38.8% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | 43.63M | +26.3% | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | 34.54M | n/a | 2023-03-01, From 2020-01-01 |
| No annual figure between 2018-12-31 and 2020-12-31. | |||
| 2018-12-31 | 19.43M | +7.9% | 2019-03-06, From 2018-01-01 |
| 2017-12-31 | 18.00M | +16.2% | 2019-03-06, From 2017-01-01 |
| 2016-12-31 | 15.49M | +8.5% | 2018-03-07, From 2016-01-01 |
| 2015-12-31 | 14.28M | +260.3% | 2018-03-07, From 2015-01-01 |
| 2014-12-31 | 3.96M | n/c | 2017-03-08, From 2014-01-01 |
| 2013-12-31 | 2.01M | n/c | 2016-03-08, From 2013-01-01 |
| 2012-12-31 | 1.33M | n/a | 2015-03-12, From 2012-01-01 |